Nephros, Inc.NEPHNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +18.93% | +38.47% | +35.89% | +35.42% | +22.20% |
| Gross Profit Growth | +22.46% | +44.22% | +46.18% | +35.64% | +5.90% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +72.35% | -92.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +52.43% | -94.32% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +84.15% | -82.23% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +82.76% | -82.48% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +76.30% | -83.38% |
| Weighted Average Shares Growth | +0.01% | +0.94% | +0.86% | +0.64% | +0.64% |
| Weighted Average Shares Diluted Growth | +0.12% | +1.09% | +2.88% | +4.35% | +3.90% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -82.36% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -82.36% |
| Receivables Growth | +19.05% | +76.35% | +8.63% | +57.36% | +35.54% |
| Inventory Growth | +5.87% | -29.69% | -20.19% | -11.65% | +23.59% |
| Asset Growth | -5.49% | +3.17% | +10.30% | +27.55% | +21.69% |
| Book Value per Share Growth | +2.71% | +12.53% | +20.07% | +21.63% | +18.07% |
| Debt Growth | -23.15% | -22.35% | -21.46% | -22.65% | -24.66% |
| R&D Expense Growth | +21.15% | +39.15% | +22.44% | +79.79% | +56.75% |
| SG&A Expenses Growth | -22.36% | +5.23% | +13.40% | +29.52% | +23.72% |